Inventiva (IVEVF) Retained Earnings (2018 - 2025)
Inventiva (IVEVF) posted Retained Earnings of -$412.2 million for Q4 2025, down 107.06% on a QoQ basis from -$199.1 million in Q2 2025, and down 109.42% year-over-year from $4.4 billion in Q4 2024.
Analysis
Inventiva (IVEVF) Retained Earnings (2018 - 2025) Analysis & Trends
Inventiva has reported Retained Earnings for 8 years, with the latest figure at -$412.2 million in Q4 2025.
- On a quarterly basis, Retained Earnings fell 109.42% year-over-year to -$412.2 million in Q4 2025; TTM through Dec 2025 was -$412.2 million, a 109.42% decrease from a year earlier, with the FY2025 full-year figure at -$412.2 million, down 109.42% from the prior year.
- Retained Earnings was -$412.2 million for Q4 2025 at Inventiva, down from -$199.1 million in the prior quarter.
- The five-year high for Retained Earnings was -$1.6 million in Q2 2024, with the low at -$412.2 million in Q4 2025.
- Average Retained Earnings over 5 years is -$111.1 million, with a median of -$56.1 million recorded in 2021.
- The sharpest annual moves came in 2022 and 2025: Retained Earnings climbed 2.48% in 2022, then sank 12151.6% in 2025.
- Over 5 years, Retained Earnings stood at -$56.8 million in 2021, then increased by 2.48% to -$55.4 million in 2022, then tumbled by 114.57% to -$118.8 million in 2023, then sank by 65.68% to -$196.8 million in 2024, then plunged by 109.42% to -$412.2 million in 2025.
- The last three Retained Earnings figures came in at -$412.2 million (Q4 2025), -$199.1 million (Q2 2025), and -$196.8 million (Q4 2024), per Business Quant data.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Retained Earnings (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 646.71 Bn | 625.95 Bn | 17.26 Bn | 171.67 Bn |
| 2 | AbbVie | 442.22 Bn | 435.65 Bn | 12.70 Bn | -17.33 Bn |
| 3 | Merck | 366.92 Bn | 359.78 Bn | 12.21 Bn | 63.27 Bn |
| 4 | Novartis Ag | 266.90 Bn | 259.21 Bn | 11.24 Bn | 40.86 Bn |
| 5 | Pfizer | 159.20 Bn | 147.50 Bn | 10.94 Bn | 112.09 Bn |
| 6 | Sanofi | 52.44 Bn | 45.06 Bn | 10.79 Bn | - |
| 7 | Revolution Medicines | 44.11 Bn | 44.11 Bn | - | -4.00 Bn |
| 8 | Incyte | 25.38 Bn | 20.85 Bn | 1.57 Bn | 1.10 Bn |
| 9 | United Therapeutics | 21.50 Bn | 18.84 Bn | 683.80 Mn | 9.16 Bn |
| 10 | Inventiva | 693.72 Mn | 693.72 Mn | - | -412.23 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Dec 31, 2025 | -412.23 Mn |
| Jun 30, 2025 | -199.09 Mn |
| Dec 31, 2024 | -196.85 Mn |
| Jun 30, 2024 | -1.63 Mn |
| Dec 31, 2023 | -118.81 Mn |
| Dec 31, 2022 | -55.37 Mn |
| Jun 30, 2022 | -31.44 Mn |
| Dec 31, 2021 | -56.78 Mn |
| Jun 30, 2021 | -27.86 Mn |
| Mar 31, 2021 | -10.66 Mn |
| Dec 31, 2020 | -40.08 Mn |
| Dec 31, 2019 | -33.45 Mn |
| Dec 31, 2018 | -37.68 Mn |